Skip to content
Trial Eligibility
Menu

ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.

NCT07699562

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study is testing whether a non-invasive nerve monitoring device (TetraGraph) can accurately detect early signs of ICU-acquired weakness by comparing readings from the device with standard nerve conduction/EMG tests done by a specialist to see if they match. They will focus on muscle response signals in the hand and leg over about 10 days in three groups: healthy volunteers, ICU patients who are not on ventilators, and ICU patients who are on ventilators.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • ICU Acquired Weakness

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 90 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Endeavor Health
Last updated on ClinicalTrials.gov
July 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Endeavor Health · Evanston, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.